Small Molecule Drug Technology Platforms

Chiral Catalysis Technology Platform

Fluorine Chemistry Technology Platform

Photocatalysis Reaction Technology Platform

Continuous Flow Technology Platform

Enzyme Catalysis Technology Platform

Solid State Research Technology Platform

• Fast. One of the key advantages of our small molecule drug technology platforms is their ability to expedite the drug development process. By leveraging our platforms, our customers can benefit from shortened timelines for drug compound discovery and synthesis, helping to bring new drugs to market more quickly and efficiently.
• Flexibility. Our small molecule drug technology platforms are highly flexible and can be customized according to the specific needs of the project. Whether you need drug intermediates, active pharmaceutical ingredients (APIs) that target a specific disease pathway or need to develop a new synthesis process, our platforms have the ability to achieve your vision.

• Innovation. Our small molecule drug technology platforms are continuously evolving and adapting to the latest scientific discoveries and advancements in drug development. By choosing our platforms, customers can access cutting-edge research and development capabilities to stay ahead of the curve in the pharmaceutical industry.
• Cost-effectiveness. Our small molecule drug technology platforms can effectively screen and optimize drug candidates, reduce production costs, and ultimately enable more cost-effective drug development.